Newsweek

The Battle Against ISIS Won't End with Iraq and Syria

Until the West crushes ISIS’s ideology, bombings like the one in Manchester are going to continue—and maybe become more common.
People look at flowers in St. Ann's Square, close to the Manchester Arena where a suicide bomber killed 22 people leaving a pop concert at the venue on Monday night.
06_09_Manchester_01

Orlando, Nice, Paris, Brussels, Berlin, Würzburg, Ansbach, Munich, London—and now Manchester. The pattern is becoming depressingly familiar. The news breaks with blurry cellphone footage—pedestrians strolling on a seaside promenade, shoppers enjoying a Christmas market, excited kids leaving a pop concert. Then come the gunshots, a rampaging truck or the jolting explosion—followed by panic, people running, inert bodies. Within the hour, politicians are on the air with a litany of condemnations and condolences.

Even more familiar: the description of the killers—loners, misfits, members of poor Muslim immigrant communities, most of them followers of the death cult known as the Islamic State militant group. Like the attackers who shot up the Bataclan theater in Paris in 2015, the suicide bombers who hit Brussels Airport six months later and the perpetrators of at least 15 attacks against the West over the past three years, Britain’s Manchester bomber was an alienated, angry young son of immigrants who got wrapped up in ISIS and decided to vent at the world by murdering innocents.

The personal motivations of all these suicide killers vary—the 22-year-old Manchester bomber, Salman Ramadan Abedi, whose parents immigrated to the U.K. from Libya, was reportedly angry at a friend’s death last year in what he felt was an

You’re reading a preview, subscribe to read more.

More from Newsweek

Newsweek12 min read
The Inconceivable Search For Sperm
SINGLE WOMEN AND LGBTQ+ COUPLES are increasingly pursuing pregnancy via known donors—people they find on the internet, in Facebook groups and through dating-like apps. In her own quest to become a solo mother by choice, investigative journalist Valer
Newsweek3 min read
Newsweek US
GLOBAL EDITOR IN CHIEF _ Nancy Cooper VICE PRESIDENT, DIGITAL _ Laura Davis DIRECTOR OF OPERATIONS _ Melissa Jewsbury OPINION EDITOR _ Batya Ungar-Sargon GLOBAL PUBLISHING EDITOR _ Chris Roberts SENIOR EDITOR-AT-LARGE _ Josh Hammer EDITORIAL Managi
Newsweek5 min read
‘Deadly Risk’ of Fat-Loss Drugs
“MIRACLE” FAT-MELTING DRUG OZEMPIC HAS been linked in a study to a series of rare but potentially fatal psychiatric episodes, scientists have warned. The injectable prescription drug was developed to manage blood sugar levels in patients with Type 2

Related Books & Audiobooks